Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis (Q33564501)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1, 1992

edit

Language	Label	Description	Also known as
English	Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis	scientific article published on April 1, 1992

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

title

Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

main subject

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

D. Porter

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

R. Madhok

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

J. A. Hunter

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

H. A. Capell

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

full work available at URL

https://europepmc.org/articles/PMC1004691

file format

HTML

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

https://europepmc.org/articles/PMC1004691?pdf=render

file format

Portable Document Format

online access status

open access

content deliverer

Europe PubMed Central

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350192

retrieved

17 September 2022

published in

Annals of the Rheumatic Diseases

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

volume

51

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

page(s)

461-464

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

cites work

Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

Long term outcome of treatment with sulphasalazine in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

Auranofin. New oral gold compound for treatment of rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1004691

retrieved

28 July 2018

Sulphasalazine in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1350192

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1350192

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1350192

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/1350192

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/ARD.51.4.461

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

PMC publication ID

1004691

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

PubMed publication ID

1350192

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1350192

retrieved

28 July 2017

ResearchGate publication ID

21805902

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33564501&oldid=1889848151"